Correlation Engine 2.0
Clear Search sequence regions


  • Ca2 (3)
  • female (1)
  • insulin (2)
  • lipid (1)
  • mdx (10)
  • mdx mice (3)
  • mice knockout (1)
  • muscle skeletal (1)
  • necrosis (1)
  • protein levels (1)
  • proteolipids (2)
  • reticulum (2)
  • SERCA (1)
  • SLN (12)
  • Sizes of these terms reflect their relevance to your search.

    Duchenne muscular dystrophy (DMD) is an inherited muscle wasting disease. Metabolic impairments and oxidative stress are major secondary mechanisms that severely worsen muscle function in DMD. Here, we sought to determine whether germline reduction or ablation of sarcolipin (SLN), an inhibitor of sarco/endoplasmic reticulum (SR) Ca2+ ATPase (SERCA), improves muscle metabolism and ameliorates muscle pathology in the mdx mouse model of DMD. Glucose and insulin tolerance tests show that glucose clearance rate and insulin sensitivity were improved in the SLN haploinsufficient mdx (mdx:sln+/-) and SLN-deficient mdx (mdx:sln-/-) mice. The histopathological analysis shows that fibrosis and necrosis were significantly reduced in muscles of mdx:sln+/- and mdx:sln-/- mice. SR Ca2+ uptake, mitochondrial complex protein levels, complex activities, mitochondrial Ca2+ uptake and release, and mitochondrial metabolism were significantly improved, and lipid peroxidation and protein carbonylation were reduced in the muscles of mdx:sln+/- and mdx:sln-/- mice. These data demonstrate that reduction or ablation of SLN expression can improve muscle metabolism, reduce oxidative stress, decrease muscle pathology, and protects the mdx mice from glucose intolerance.

    Citation

    Rekha Balakrishnan, Satvik Mareedu, Gopal J Babu. Reducing sarcolipin expression improves muscle metabolism in mdx mice. American journal of physiology. Cell physiology. 2022 Feb 01;322(2):C260-C274

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34986021

    View Full Text